[Scleroderma renal crisis following withdrawal of therapy with losartan].
Jego
C
C
Michaut
V
V
Graffin
B
B
Paris
J-F
JF
Carli
P
P
D000208:Acute Disease; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D015984:Causality; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D019808:Losartan / Q000009:adverse effects*; D018810:Magnetic Resonance Angiography; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D013256:Steroids; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D018608:Ultrasonography, Doppler
D000893:Anti-Inflammatory Agents; D000959:Antihypertensive Agents; D013256:Steroids; D019808:Losartan
Apparition d'une crise rénale sclérodermique à l'arrêt d'un traitement par losartan.